COV-QUANTO® is a test for the quantitative detection of the SARS-CoV-2 nucleocapsid antigen from a blood sample (serum/plasma) obtained by venipuncture.
COV-QUANTO® has been evaluated and validated by an expert Paris hospital laboratory on more than 200 samples. The authors of the evaluation study(1) emphasize that “this innovative marker opens up new perspectives for the diagnosis of COVID-19 only requiring a blood draw, scalable in all clinical laboratories”.
COV-QUANTO® is based on the ELISA technique and is performed in 2 hours.
Ref : TL-COV-001
(1) SARS-CoV-2 N antigenemia : A new potential alternative to nucleic acid amplification techniques, Q. Le Hingrat, Septembre 2020
COV-QUANTO® is an immunochromatographic assay for the quantitative detection of the nucleocapsid protein of SARS-CoV-2 (N protein) in human serum or plasma for use by healthcare professionals.
This test is reliable for the detection of SARS-CoV-2 infections during the incubation period that can range from 1 to 14 days but is usually 3 to 7 days.
Read the instructions in the package insert carefully.
Manufactured and distributed by : AAZ-LMB 43 rue de Bellevue 92100 Boulogne-Billancourt, FRANCE
This in vitro diagnostic medical device is a regulated health product which, under these regulations, bears the CE mark.
Internal page reference : AAZ.CQ-24-A (created on 2020/10/27) webpage